Skip to main content

SQZ Biotechnologies Co

SQZDelisted Jul 19, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001604477

SQZ Biotechnologies Co was delisted on Jul 19, 2023; its insiders filed their last Form 4 on Jun 15, 2023; 31 institutions reported holding it in 13F filings for Q2 2023, worth $2.96M in total; Maverick Capital was the only superinvestor holding it.

Q4 2021 vs. Q3 2021

How the institutions holding SQZ Biotechnologies Co changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of SQZ: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders4450+6
Shares13.8M15.6M+1.80M (+13.0%)
Value$199.1M$139.5M−$59.7M (−30.0%)

New holders (10)

Institutions that held SQZ Biotechnologies Co at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to SQZ in Q4 2021
InstitutionSharesValue% of portfolio
NanoDimension, Inc.1,445,221$12.9M11.57%
Sandy Cove Advisors, LLC51,707$462.0K0.39%
Two Sigma Advisers, LP18,600$166.0K0.00%
Allspring Global Investments Holdings, LLC18,431$164.0K0.00%
PDT Partners, LLC12,777$114.0K0.01%
Virtu Financial LLC12,572$112.0K0.01%
Citadel Advisors LLC11,844$106.0K0.00%
Bangor Savings Bank11,054$99.0K0.01%
Toronto Dominion Bank3$00.00%
Simplex Trading, LLC100$00.00%

Sold out (4)

Institutions that held SQZ Biotechnologies Co at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of SQZ in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
MetLife Investment Management9,534$137.5K
Metropolitan Life Insurance Co7,213$104.0K
Rockefeller Capital Management L.P.890$12.0K
Harbour Investments, Inc.13$0